A phase I/II study of altered fractionated imrt alone for intermediate t-stage oropharyngeal carcinoma

Strahlentherapie und Onkologie

Volumn 186, Issue 9, 2010, Pages 489-495

  Gunn, G Brandon ^a   Endres, Eugene J ^a   Parker, Brent ^a   Sormani, Maria Pia ^b   Sanguineti, Giuseppe ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Altered fractionation; Intensity modulated radiation therapy; Oropharynx cancer

Indexed keywords

ADULT; AGED; AGEUSIA; ARTICLE; BONE NECROSIS; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DERMATITIS; DISTANT METASTASIS; DRUG EFFICACY; DYSPHAGIA; FEMALE; FIBROSIS; FOLLOW UP; HEARING LOSS; HIGH RISK PATIENT; HUMAN; HYPOTHYROIDISM; INFECTION; INTENSITY MODULATED RADIATION THERAPY; MALE; MUCOSA INFLAMMATION; MYELITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PAIN; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SALIVARY GLAND DISEASE; SECOND CANCER; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TRISMUS; TUMOR VOLUME; WEIGHT REDUCTION; XEROSTOMIA;

FEASIBILITY STUDIES; GASTROSTOMY; HUMANS; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; RADIOTHERAPY, INTENSITY-MODULATED; SKIN; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 77957758819     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-010-2093-6     Document Type: Article

References (47)

1. K.K. Ang 1998 Altered fractionation in the management of head and neck cancer Int J Radiat Biol 73 395 9 1:CAS:528:DyaK1cXivF2hsbs%3D 10.1080/095530098142220 9587077 (Pubitemid 28202112)
2. K.K. Ang B.A. Berkey T.F. Pajak K.K. Fu 2002 In response to Drs. Dubben, Beck-Bornholdt, and Llogie Int J Radiat Oncol Biol Phys 52 1148 50 11958923
3. M.A. Ben-David M. Diamante J.D. Radawski 2007 Lack of osteoradionecrosis of the mandible after intensity-modulated radiotherapy for head and neck cancer: likely contributions of both dental care and improved dose distributions Int J Radiat Oncol Biol Phys 68 396 402 17321069
4. S.M. Bentzen M. Vaeth D.E. Pedersen 1995 Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment... now! Int J Radiat Oncol Biol Phys 32 1531 4 1:STN:280:DyaK2Mzmt1Khsw%3D%3D 7635798
5. S. Bieri S.M. Bentzen P. Huguenin 2003 Early morbidity after radiotherapy with or without chemotherapy in advanced head and neck cancer. Experience from four nonrandomized studies Strahlenther Onkol 179 390 5 12789465
6. E. Bölke P.A. Gerber G. Lammering 2008 Development and management of severe cutaneous side effects in head-and-neck cancer patients during concurrent radiotherapy and cetuximab Strahlenther Onkol 184 105 10 10.1007/s00066-008-1829-z 18259703 (Pubitemid 351231657)
7. J.A. Bonner P.M. Harari J. Giralt 2006 Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 567 78 1:CAS:528:DC%2BD28Xhtleksbs%3D 10.1056/NEJMoa053422 16467544 (Pubitemid 43209104)
8. J. Bourhis J. Overgaard H. Audry 2006 Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis Lancet 368 843 54 10.1016/S0140-6736(06)69121-6 16950362 (Pubitemid 44292807)
9. R.J. Caplan T.F. Pajak J.D. Cox 1994 Analysis of the probability and risk of cause-specific failure Int J Radiat Oncol Biol Phys 29 1183 6 1:STN:280:DyaK2czmsVynug%3D%3D 7521864
10. K.S. Chao G. Ozyigit A.I. Blanco 2004 Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume Int J Radiat Oncol Biol Phys 59 43 50 15093897
11. R. Corvò M. Benasso G. Sanguineti 2001 Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck: results from a phase III randomized trial Cancer 92 2856 67 10.1002/1097-0142(20011201)92:11<2856:: AID-CNCR10132>3.0.CO;2-6 11753959 (Pubitemid 33091921)
12. J.D. Cox J. Stetz T.F. Pajak 1995 Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1341 6 1:STN:280:DyaK2M3ivFCrsA%3D%3D 7713792
13. F.F. de Arruda D.R. Puri J. Zhung 2006 Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience Int J Radiat Oncol Biol Phys 64 363 73 15925451
14. A. Delana L. Menegotti A. Bolner 2009 Impact of residual setup error on parotid gland dose in intensity-modulated radiation therapy with or without planning organ-at-risk margin Strahlenther Onkol 185 453 9 10.1007/s00066-009- 1888-9 19714307
15. F. Denis P. Garaud E. Bardet 2003 Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/ SOMA, RTOG/EORTC, and NCI-CTC scoring systems Int J Radiat Oncol Biol Phys 55 93 8 10.1016/S0360-3016(02)03819-1 12504040 (Pubitemid 36020347)
16. F. Denis P. Garaud E. Bardet 2004 Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma J Clin Oncol 22 69 76 10.1200/JCO.2004.08.021 14657228 (Pubitemid 41095116)
17. N. Dogan S. King B. Emami 2003 Assessment of different IMRT boost delivery methods on target coverage and normal-tissue sparing Int J Radiat Oncol Biol Phys 57 1480 91 14630288
18. A. Eisbruch 2002 Intensity-modulated radiotherapy of head-and-neck cancer: encouraging early results Int J Radiat Oncol Biol Phys 53 1 3 12007933
19. A. Eisbruch J. Harris A.S. Garden 2007 Multi-institutional trial of IMRT for early stage oropharyngeal cancer: acceleration via simultaneously incorporated boost (SIB) (RTOG 00-22) Int J Radiat Oncol Biol Phys 67 438 44
20. A. Eisbruch J.A. Ship L.A. Dawson 2003 Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer World J Surg 27 832 7 10.1007/s00268-003-7105-6 14509515 (Pubitemid 37022398)
21. C. Fakhry W.H. Westra S. Li 2008 Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial J Natl Cancer Inst 100 261 9 1:CAS:528:DC%2BD1cXisVKgs7o%3D 10.1093/jnci/djn011 18270337 (Pubitemid 351480538)
22. J.F. Fowler 2007 Is there an optimum overall time for head and neck radiotherapy? A review, with new modeling Clin Oncol (R Coll Radiol) 19 8 22 1:STN:280:DC%2BD2s7gsFKhtQ%3D%3D
23. K.K. Fu T.F. Pajak A. Trotti 2000 A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003 Int J Radiat Oncol Biol Phys 48 7 16 1:STN:280:DC%2BD3czps1aqsQ%3D%3D 10.1016/S0360-3016(00)00663-5 10924966 (Pubitemid 30488207)
24. A.S. Garden W.H. Morrison D.I. Rosenthal 2004 Target coverage for head and neck cancers treated with IMRT: review of clinical experiences Semin Radiat Oncol 14 103 9 10.1053/j.semradonc.2003.12.004 15095256 (Pubitemid 38586104)
25. A.S. Garden W.H. Morrison P.F. Wong 2007 Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma Int J Radiat Oncol Biol Phys 67 438 44 17141972
26. V. Gregoire P. Maingon 2004 Intensity-modulated radiation therapy in head and neck squamous cell carcinoma: an adaptation of 2-dimensional concepts or a reconsideration of current clinical practice Semin Radiat Oncol 14 110 20 10.1053/j.semradonc.2003.12.006 15095257 (Pubitemid 38586105)
27. J.T. Gwozdz W.H. Morrison A.S. Garden 1997 Concomitant boost radiotherapy for squamous carcinoma of the tonsillar fossa Int J Radiat Oncol Biol Phys 39 127 35 1:STN:280:DyaK2svksVaitw%3D%3D 9300747
28. J.C. Horiot R. Le Fur T. N'Guyen 1992 Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC Cooperative Group of Radiotherapy Radiother Oncol 25 231 41 1:STN:280:DyaK3s7is1GqsA%3D%3D 10.1016/0167-8140(92)90242-M 1480768 (Pubitemid 23000765)
29. A. Lauve M. Morris R. Schmidt-Ullrich 2004 Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II - clinical results Int J Radiat Oncol Biol Phys 60 374 87 10.1016/j.ijrobp.2004.07.154 15380569
30. N. Lee C. Chuang J.M. Quivey 2002 Skin toxicity due to intensity-modulated radiotherapy for head-and-neck carcinoma Int J Radiat Oncol Biol Phys 53 630 7 10.1016/S0360-3016(02)02859-6 12062606 (Pubitemid 34787877)
31. N.Y. Lee F.F. de Arruda D.R. Puri 2006 A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma Int J Radiat Oncol Biol Phys 66 966 74 17145527
32. M. Machtay J. Moughan A. Trotti 2008 Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis J Clin Oncol 26 3582 9 1:CAS:528:DC%2BD1cXpvVWmtLc%3D 10.1200/JCO.2007.14.8841 18559875
33. R. Mohan Q. Wu M. Manning 2000 Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers Int J Radiat Oncol Biol Phys 46 619 30 1:STN:280:DC%2BD3c7mtlKktA%3D%3D 10701741
34. J. Overgaard H.S. Hansen L. Specht 2003 Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial Lancet 362 933 40 10.1016/S0140-6736(03)14361-9 14511925 (Pubitemid 37159288)
35. M.S. Pepe G. Longton M. Thournquist 1991 A qualifier Q for the survival function to describe the prevalence of a transient condition Stat Med 10 413 21 1:STN:280:DyaK3M3islKrtQ%3D%3D 10.1002/sim.4780100313 2028125
36. L.J. Peters R.H. Withers B.W. Brown 1995 Complicating issues in complicating reporting Int J Radiat Oncol Biol Phys 31 1349 51 1:STN:280:DyaK2M3ivFCrtg%3D%3D 7755796
37. N.G. Rao G. Sanguineti G. Chaljub 2008 Do neck levels that are negative on initial CT need to be dissected after definitive radiation therapy with or without chemotherapy? Head Neck 30 1090 8 10.1002/hed.20842 18528904
38. D.I. Rosenthal K.K. Ang 2004 Altered radiation therapy fractionation, chemoradiation, and patient selection for the treatment of head and neck squamous carcinoma [Review] Semin Radiat Oncol 14 153 66 10.1053/j.semradonc. 2004.01.001 15095261 (Pubitemid 38586109)
39. G. Sanguineti P. Adapala E.J. Endres 2007 Dosimetric predictors of laryngeal edema Int J Radiat Oncol Biol Phys 68 741 9 17398024
40. G. Sanguineti G.B. Gunn E.J. Endres 2006 Is there a "mucosa- sparing" benefit of IMRT for head-and-neck cancer? Int J Radiat Oncol Biol Phys 66 931 8 17011465
41. G. Sanguineti G.B. Gunn E.J. Endres 2008 Patterns of locoregional failure after exclusive IMRT for oropharyngeal carcinoma Int J Radiat Oncol Biol Phys 72 737 46 18486356
42. F. Sterzing K. Schubert G. Sroka-Perez 2008 Helical tomotherapy. Experiences of the first 150 patients in Heidelberg Strahlenther Onkol 184 8 14 10.1007/s00066-008-1778-6 18188517
43. G. Studer U.M. Luetolf C. Glanzmann 2007 Locoregional failure analysis in head-and-neck cancer patients treated with IMRT Strahlenther Onkol 183 417 23 10.1007/s00066-007-1663-8 17680220 (Pubitemid 47230517)
44. G. Studer S.P. Studer R.A. Zwahlen 2006 Osteoradionecrosis of the mandible: minimized risk profile following intensity-modulated radiation therapy (IMRT) Strahlenther Onkol 182 283 8 10.1007/s00066-006-1477-0 16673062
45. S.J. Thomas A.C. Hoole 2004 The effect of optimization on surface dose in intensity modulated radiotherapy (IMRT) Phys Med Biol 49 4919 28 10.1088/0031-9155/49/21/005 15584527 (Pubitemid 39489932)
46. M. Voordeckers H. Everaert K. Tournel 2008 Longitudinal assessment of parotid function in patients receiving tomotherapy for head-and-neck cancer Strahlenther Onkol 184 400 5 10.1007/s00066-008-1836-0 18956516
47. M. Yao T. Nguyen J.M. Buatti 2006 Changing failure patterns in oropharyngeal squamous cell carcinoma treated with intensity modulated radiotherapy and implications for future research Am J Clin Oncol 29 606 12 10.1097/01.coc.0000242294.89536.d6 17148999 (Pubitemid 44915298)